We are live on ! Find out more
SEC

Seven Eight Capital Portfolio holdings

AUM $1.11B
1-Year Est. Return 29.48%
This Fund
S&P 500
This Quarter Est. Return
-6.56%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$855M
AUM Growth
+$250M
Cap. Flow
+$327M
Cap. Flow %
38.29%
Top 10 Hldgs %
13.1%
Holding
788
New
316
Increased
155
Reduced
106
Closed
211

Top Buys

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$13.6M
2
MRK icon
Merck
MRK
+$12.5M
3
ISRG icon
Intuitive Surgical
ISRG
+$11.1M
4
DOCU
DocuSign
DOCU
+$10.9M
5
PODD icon
Insulet
PODD
+$10.8M

Sector Composition

Rank Sector Weight
1 Technology 20.41%
2 Consumer Discretionary 17.68%
3 Healthcare 16.13%
4 Industrials 12.13%
5 Financials 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCHP icon
676
Microchip Technology
MCHP
$43.5B
-6,268
Closed -$562K
MCO icon
677
Moody's
MCO
$83.5B
-977
Closed -$340K
MDLZ icon
678
Mondelez International
MDLZ
$78.7B
-17,597
Closed -$1.28M
MELI icon
679
Mercado Libre
MELI
$95B
-391
Closed -$463K
MKL icon
680
Markel Group
MKL
$23.3B
-303
Closed -$419K
MLI icon
681
Mueller Industries
MLI
$15.1B
-30,896
Closed -$674K
MMM icon
682
3M
MMM
$92.8B
-51,347
Closed -$4.3M
MMSI icon
683
Merit Medical Systems
MMSI
$5.08B
-3,833
Closed -$321K
MO icon
684
Altria Group
MO
$114B
-12,915
Closed -$585K
MS icon
685
Morgan Stanley
MS
$343B
-14,443
Closed -$1.23M
MSTR icon
686
Strategy Inc
MSTR
$35B
-69,240
Closed -$2.37M
MTDR icon
687
Matador Resources
MTDR
$6.02B
-15,335
Closed -$802K
MUSA icon
688
Murphy USA
MUSA
$10.8B
-2,327
Closed -$724K
NBIX icon
689
Neurocrine Biosciences
NBIX
$17.1B
-6,430
Closed -$606K
NDAQ icon
690
Nasdaq
NDAQ
$52.3B
-145,640
Closed -$7.26M
NEM icon
691
Newmont
NEM
$103B
-82,528
Closed -$3.52M
NET icon
692
Cloudflare
NET
$106B
-33,214
Closed -$2.17M
NSIT icon
693
Insight Enterprises
NSIT
$4.23B
-2,681
Closed -$392K
NSSC icon
694
Napco Security Technologies
NSSC
$1.41B
-6,122
Closed -$212K
NTAP icon
695
NetApp
NTAP
$38.2B
-16,959
Closed -$1.3M
NTNX icon
696
Nutanix
NTNX
$16.7B
-7,220
Closed -$203K
NUE icon
697
Nucor
NUE
$62B
-4,235
Closed -$694K
NVO
698
Novo Nordisk
NVO
$197B
-29,612
Closed -$2.4M
NVT icon
699
nVent Electric
NVT
$26.3B
-5,783
Closed -$299K
OC icon
700
Owens Corning
OC
$11.6B
-2,288
Closed -$299K

Similar funds

Seven Eight Capital's Q3 2023 Portfolio in Review

As of Q3 2023, Seven Eight Capital held 788 positions worth $855M, up 41% from $605M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Seven Eight Capital deployed $327M of net new capital in Q3 2023, opening 316 new positions and adding to 155 existing holdings. Its largest new stake was Merck: 115,677 shares worth $11.9M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was BioMarin Pharmaceuticals, an estimated $6.86M trimmed.

  • Seven Eight Capital's largest Q3 2023 buy was Merck: 115,677 shares worth $11.9M.
  • Seven Eight Capital added most to Edwards Lifesciences in Q3 2023, an estimated $13.6M increase.
  • Seven Eight Capital's biggest Q3 2023 reduction was BioMarin Pharmaceuticals, cutting an estimated $6.86M.
  • Seven Eight Capital fully exited Nasdaq in Q3 2023, selling an estimated $7.26M.
  • Seven Eight Capital's ten largest holdings make up 13% of its $855M portfolio in Q3 2023.
  • Seven Eight Capital opened 316 new positions and closed 211 in Q3 2023.
  • Seven Eight Capital's portfolio value rose 41% quarter-over-quarter to $855M.

Based on Seven Eight Capital's 13F filing for Q3 2023, filed 14 Nov 2023.